SNAC2.

Trial name or title	SNAC2/ACTRN12605000409673
Methods	Study design: RCT (multi‐centre) Country: New Zealand, Australia (?)
Participants	Inclusion criteria: histologically or cytologically confirmed invasive breast cancer, single or multiple ipsilateral primary breast cancer, primary breast cancer may be less than or greater than 3 cm Exclusion criteria: in situ carcinoma only, clinically involved nodes for which the investigator deems axillary clearance is essential, evidence of metastatic disease, previous breast cancer or in situ carcinoma in the same breast
Interventions	SLNB (+ ALND if SLNB positive) vs SLNB + ALND
Outcomes	Locoregional recurrence, overall survival, distant disease‐free survival
Starting date	2006
Contact information	Dr Ian Campbell (Study Chair), Department of Surgery, Waikato Hospital, Private Bag 3200, Hamilton, New Zealand, Tel: +64 7 8398899 (Ext. 8279), email: CAMPBELI@waikatodhb.govt.nz Xanthi Coskinas (Trial Co‐ordinator), National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Locked Bag 77, Camperdown NSW 1450, Australia. Tel: +61 2 95625049, email: xanthi.coskinas@ctc.usyd.edu.au. Trial web site: http://www.ctc.usyd.edu.au/trials/cancer/breast.htm
Notes